ProfileGDS4132 / 214623_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 38% 36% 41% 38% 41% 38% 38% 41% 40% 39% 33% 39% 35% 36% 28% 36% 34% 45% 38% 42% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 10199.294338
GSM201543Muscle PCOS pioglitazone 12184.262336
GSM201544Muscle PCOS pioglitazone 161109.57441
GSM201545Muscle PCOS pioglitazone 201104.0338
GSM201829Muscle PCOS pioglitazone 231114.48741
GSM201830Muscle PCOS pioglitazon 251101.10338
GSM201831Muscle PCOS pioglitazone 27197.566938
GSM201832Muscle PCOS pioglitazone 31106.21441
GSM201833Muscle PCOS pioglitazone 4198.087340
GSM201834Muscle PCOS pioglitazone 8197.18239
GSM201835Muscle PCOS after pioglitazone 10268.084733
GSM201836Muscle PCOS after pioglitazone 12289.935939
GSM201837Muscle PCOS after pioglitazone 16273.046235
GSM201838Muscle PCOS after pioglitazone 20283.103836
GSM201839Muscle PCOS after pioglitazone 23260.647628
GSM201840Muscle PCOS after pioglitazone 25288.209236
GSM201841Muscle PCOS after pioglitazone 27269.932834
GSM201842Muscle PCOS after pioglitazone 3298.39845
GSM201843Muscle PCOS after pioglitazone 4294.540938
GSM201844Muscle PCOS after pioglitazone 82103.78942